Who has been buying BrightPath Biotherapeutics Co., Ltd. stock?

8 distinct investors have filed 11 disclosed large-shareholding filings in BrightPath Biotherapeutics Co., Ltd. (4594), most recently on 2026-02-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does BrightPath Biotherapeutics Co., Ltd. have?

BrightPath Biotherapeutics Co., Ltd. has 11 buy-side and 50 sell-side disclosures on record, covering ¥6.4B ($41.4M) in total reported value, spanning 2021-04-07 to 2026-02-19.

Where does StockDrifts get BrightPath Biotherapeutics Co., Ltd. insider data?

From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.

Do insider buys in Japanese stocks predict returns?

Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

BrightPath Biotherapeutics Co., Ltd. 4594

Company

ブライトパス・バイオ株式会社BrightPath Biotherapeutics Co., Ltd.

Investors

Buys

Total Value

¥6.4B ($41.4M)

Avg Return

-35.85%

Last Filing

2026-02-19

BrightPath Biotherapeutics Co., Ltd. (4594) has 11 disclosed large-shareholding filings and 50 disclosed disposals on record, filed by 8 distinct investors. Together those filings cover ¥6.4B ($41.4M) in reported transaction value. The earliest filing StockDrifts holds for BrightPath Biotherapeutics Co., Ltd. is dated 2021-04-07; the most recent is 2026-02-19. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is -35.85%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

Date	Type	Source	Insider	Purpose	Shares	Price at filing	Return	Value
2026-02-19	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	5.7M	¥72	+9.7%	¥113M ($730K)
2026-01-29	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	7.5M	¥63	-3.2%	¥70M ($453K)
2026-01-21	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	8.8M	¥73	+11.0%	¥159M ($1.0M)
2026-01-20	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	11.3M	¥72	+9.7%	¥778M ($5.0M)
2026-01-06	BUY	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	26.0M	¥49	+32.6%	¥47M ($303K)
2026-01-06	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd.	passive	25.6M	¥49	-32.6%	¥60M ($387K)
2025-12-17	BUY	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd	passive	27.1M	¥48	+35.4%	¥12M ($79K)
2025-12-17	SELL	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd	passive	27.1M	¥48	-35.4%	¥19M ($124K)
2025-12-17	BUY	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd	passive	27.5M	¥48	+35.4%	¥1.3B ($8.5M)
2025-12-17	BUY	Market Buy	フィリップ証券株式会社 Phillip Securities Japan,Ltd	passive	27.5M	¥48	+35.4%	¥1.3B ($8.5M)
2025-07-11	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥64	+1.6%	-
2025-07-11	SELL	Market Buy	エボファンド Evo Fund	activist	5.4M	¥64	-1.6%	¥238M ($1.5M)
2025-07-10	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥67	-3.0%	-
2025-07-10	SELL	Market Buy	エボファンド Evo Fund	activist	9.3M	¥67	+3.0%	¥219M ($1.4M)
2025-06-27	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥47	+38.3%	-
2025-06-27	SELL	Market Buy	エボファンド Evo Fund	activist	12.9M	¥47	-38.3%	¥214M ($1.4M)
2025-06-24	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥51	+27.4%	-
2025-06-24	SELL	Market Buy	エボファンド Evo Fund	activist	17.9M	¥51	-27.4%	¥57M ($367K)
2025-05-27	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥39	+66.7%	-
2025-05-27	SELL	Market Buy	エボファンド Evo Fund	activist	19.3M	¥39	-66.7%	¥31M ($200K)
2025-05-08	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥39	+66.7%	-
2025-05-08	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥39	+66.7%	-
2025-05-08	SELL	Market Buy	エボファンド Evo Fund	activist	20.2M	¥39	-66.7%	¥38M ($244K)
2025-05-08	SELL	Market Buy	エボファンド Evo Fund	activist	20.2M	¥39	-66.7%	¥38M ($244K)
2025-04-17	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥40	+62.5%	-
2025-04-17	SELL	Market Buy	エボファンド Evo Fund	activist	21.4M	¥40	-62.5%	¥34M ($222K)
2025-03-31	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥44	+47.7%	-
2025-03-31	SELL	Market Buy	エボファンド Evo Fund	activist	22.4M	¥44	-47.7%	¥40M ($261K)
2025-02-27	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥45	+44.4%	-
2025-02-27	SELL	Market Buy	エボファンド Evo Fund	activist	23.6M	¥45	-44.4%	¥43M ($280K)
2025-01-31	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥43	+51.2%	-
2025-01-31	SELL	Market Buy	エボファンド Evo Fund	activist	24.8M	¥43	-51.2%	¥39M ($249K)
2024-12-10	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥50	+30.0%	-
2024-12-10	SELL	Market Buy	エボファンド Evo Fund	activist	25.9M	¥50	-30.0%	¥44M ($286K)
2024-11-26	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥55	+18.2%	-
2024-11-26	SELL	Market Buy	エボファンド Evo Fund	activist	27.0M	¥55	-18.2%	¥34M ($219K)
2024-10-25	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥42	+54.8%	-
2024-10-25	SELL	Market Buy	エボファンド Evo Fund	activist	27.8M	¥42	-54.8%	¥42M ($270K)
2024-09-27	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥53	+22.6%	-
2024-09-27	SELL	Market Buy	エボファンド Evo Fund	activist	29.1M	¥53	-22.6%	¥46M ($297K)
2024-08-26	SELL	private	エボファンド Evo Fund	activist	30.3M	¥60	-8.3%	¥574K ($4K)
2024-08-26	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥60	+8.3%	-
2024-08-14	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥58	+12.1%	-
2024-08-14	SELL	private	エボファンド Evo Fund	activist	31.6M	¥58	-12.1%	¥663K ($4K)
2024-07-26	SELL	subscription	マッコーリーバンクリミテッド Macquarie Bank Limited	passive	1.4M	¥66	+1.5%	¥197M ($1.3M)
2024-07-25	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥64	+1.6%	-
2024-07-25	SELL	private	エボファンド Evo Fund	activist	33.2M	¥64	-1.6%	¥1M ($7K)
2024-07-16	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥64	+1.6%	-
2024-07-16	SELL	private	エボファンド Evo Fund	activist	35.6M	¥64	-1.6%	¥1M ($9K)
2024-07-12	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥66	-1.5%	-

Showing the 50 most recent of 84 filings.

Frequently asked questions

Who has been buying BrightPath Biotherapeutics Co., Ltd. stock?: 8 distinct investors have filed 11 disclosed large-shareholding filings in BrightPath Biotherapeutics Co., Ltd. (4594), most recently on 2026-02-19. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does BrightPath Biotherapeutics Co., Ltd. have?: BrightPath Biotherapeutics Co., Ltd. has 11 buy-side and 50 sell-side disclosures on record, covering ¥6.4B ($41.4M) in total reported value, spanning 2021-04-07 to 2026-02-19.
Where does StockDrifts get BrightPath Biotherapeutics Co., Ltd. insider data?: From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?: Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for BrightPath Biotherapeutics Co., Ltd.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.